Comments on ICER’s Draft Evidence Report: High Cholesterol Therapies
December 10, 2020
![](https://instituteforpatientaccess.org/wp-content/uploads/2020/12/Screen-Shot-2020-12-10-at-3.42.49-PM-700x907.png)
Effective treatments that reduce the risk factors associated with ASCVD offers tremendous value to the patient community.
Tags: Cardiovascular, Cost ValueCategorized in: Analysis